This consensus statement further demonstrates the critical role that the NMR LipoProfile test can play for the millions of people with diabetes or cardiovascular disease risk, says Rick Brajer, Chief Executive Officer and President, LipoScience, Inc. Measuring LDL particle number by NMR presents physicians and patients with the opportunity to better manage cardiometabolic risk.
'/>"/>
| Contact: Maura Siefring msiefring@dorland.com 267-765-3974 Dorland Global Public Relations Source:Eurekalert |